Federal Gov't Can Learn From State Drug Pricing Efforts
The federal government's interest in regulating prescription drug pricing has not dissipated, even as the government looks to the biopharmaceutical industry to expeditiously innovate and bring to market and distribute COVID-19...To view the full article, register now.
Already a subscriber? Click here to view full article